Onemednet Corporation ONMD

Q2 FY2026 · ended Jun 30, 2026 · Revenue $292,000, +88.4% YoY · Filed Aug 14, 2026

Onemednet Corporation (ONMD) files with the SEC under industry code 8731, Services-Commercial Physical & Biological Research. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $292,000 and a net loss of $2.2 million. Free cash flow was -$1.9 million. As of Jun 30, 2026 it held $358,000 in cash and investments and $132,000 in total debt.

Revenue
$292,000
+88.4% vs year-ago quarter
Net income
$-2.17M
-172.8% vs year-ago quarter
Operating cash flow
$-1.88M
+14.3% vs year-ago quarter
Free cash flow
$-1.88M
+14.1% vs year-ago quarter
EPS
$-0.04
-157.1% vs year-ago quarter
Dividend per share
None
Shares outstanding
59.29M
+28.6% vs year-ago quarter
Net cash
$226,000
Q2 FY2026
Operating margin
-696.2%
TTM

Company profile

Industry
Services-Commercial Physical & Biological Research (SIC 8731)
Listed as
ONMD (Nasdaq), ONMDW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Surrey, United Kingdom
SEC filer status
, Emerging growth company
SEC CIK
1849380
Former names
Data Knights Acquisition Corp. (until Nov 7, 2023)

Other Services-Commercial Physical & Biological Research companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Revenue
$292,000
$96,000
$891,000
$177,000
$155,000
Operating income
-$2.3M
-$2.6M
-$3.1M
-$2.2M
-$2.1M
Net income
-$2.2M
-$2.5M
-$3.1M
-$741,000
$3.0M
Diluted EPS
-$0.04
-$0.04
-$0.06
-$0.01
$0.07
Operating cash flow
-$1.9M
-$1.5M
-$1.7M
-$1.7M
-$2.2M
Free cash flow
-$1.9M
-$1.5M
-$1.7M
-$1.7M
-$2.2M
Total assets
$1.4M
$1.5M
$2.2M
$1.5M
$2.3M
Total liabilities
$4.9M
$5.6M
$5.1M
$5.4M
$6.2M
Stockholders' equity
-$3.5M
-$4.1M
-$3.0M
-$3.9M
-$3.8M
Cash and investments
$358,000
$233,000
$585,000
$149,000
$122,000
Total debt
$132,000
$176,000
$220,000
—
—

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Other events
Oct 14, 2026 Oct 13, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Sep 29, 2026 Sep 26, 2026
8-K Current report
Officer or director change, Shareholder vote results
Sep 23, 2026 Sep 18, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Other events
Jul 24, 2026 Jul 24, 2026
8-K Current report
Material agreement
Jul 1, 2026 Jul 1, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.